Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-24

Clinical Trial Update: Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of Lapaquistat Acetate in combination with atorvastatin for lowering blood cholesterol levels in adults with primary hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lapaquistat Acetate (lapaquistat acetate)
  • atorvastatin (atorvastatin)

Snippet

Sponsor: Takeda | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED